// App-Quantinova.ai

FRI0358 : USAGE OF C-REACTIVE PROTEIN TESTING IN THE DIAGNOSIS AND MONITORING OF PSORIATIC ARTHRITIS (PSA): RESULTS FROM A REAL-WORLD SURVEY IN THE US AND EUROPE

Researchers

Presenter

  • A. Ogdie

Principal Investigators

  • W. Tillett

  • L. Eder

  • N. Booth

  • S. Bruce Wirta

  • O. Howell

  • A. Schubert

  • S. Peterson

  • S. D. Chakravarty

  • L. C. Coates

Medical Centers

  • Perelman School of Medicine, Philadelphia, PA, United States of America

  • University of Bath, Bath, United Kingdom

  • Adelphi Real World, Bollington, United Kingdom

  • , Janssen-Cilag, Solna, Sweden

  • Janssen-Cilag, Warsaw, Poland

  • , Janssen Global Services, LLC, Horsham, PA, United States of America

  • Janssen Scientific Affairs, LLC, Raritan, United States of America

  • Temple University School of Medicine, Philadelphia, Pennsylvania, United States

  • University of Oxford, Oxford, United Kingdom

Locations

  • United States

  • United Kingdom

  • Canada

  • Sweden

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • Psoriatic arthritis

Biomarkers

  • C reactive protein

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved